Biotech · Private company
Tenet Medicines
Track this companyFree. Adds Tenet Medicines to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- VB119Phase 2 · Membranous NephropathyClinicalTrials.gov · fetched Nov 12, 2026
- VB119Phase 2 · Minimal Change DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)PHASE2 · TERMINATED · started May 3, 2022ClinicalTrials.gov NCT05441826 · fetched Nov 12, 2026
- Efficacy and Safety of VB119 in Subjects With Membranous NephropathyPHASE1_PHASE2 · TERMINATED · started May 5, 2021ClinicalTrials.gov NCT04652570 · fetched Nov 12, 2026